Patients Undergoing Laparoscopic Surgery Recover Faster

Published Mar 17, 2013
Surrey, UK - Previous research concludes that there is no significant difference between health-related quality of life (HRQoL) outcomes from open and laparoscopic colorectal surgery, but few studies have focussed on the early post operative recovery period when differences between open and laparoscopic surgery are potentially greatest. The paper, “Quality of Life in the First 6 Weeks Following Laparoscopic and Open Colorectal Surgery,” published in Value in Health, reports the findings from a study in a district general hospital in England that collected HRQoL measurements from patients following laparoscopic and open colorectal surgery during the first six weeks post surgery. The study sought to identify any HRQoL benefits that the faster healing following laparoscopic surgery might bring. This was the largest single institution study comparing the recovery of patients following laparoscopic versus open colorectal resection, and the first to focus heavily on outcomes in the first six weeks post surgery through frequent HRQoL measurements. The patients’ recovery was assessed using two widely used and validated HRQoL questionnaires (SF-36 and EQ-5D). The findings demonstrate a significantly improved HRQoL in the laparoscopic group compared to the open group during the first six weeks after surgery. The results were consistent across both HRQoL measures. The HRQoL findings were further validated by self-reported data showing an earlier return to normal activities and driving in the laparoscopic group. Lead author, Dr. Heather Gage, PhD from the Department of Economics at the University of Surrey, UK, states, “This paper provides new evidence that confirms that laparoscopic surgery gives most cancer patients a better recovery from colorectal resection than open approaches.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies

Apr 28, 2026

Value in Health announced the publication of a special themed section of research papers that advances evidence and methods for evaluating the real-world value of digital health technologies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×